Tradestie Institutional Equity Comparison Engine
RACC vs MPLT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RACC Overall Edge
RACC Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to RACC (RACC) driven by superior Momentum & Technical, Options & Structure while MPLT counters with relative strength in Growth & Margin. Fundamentally, RACC trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MPLT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RACC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MPLT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
RACC N/M vs MPLT N/M Fwd P/E
Growth & Margin Winner
MPLT
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
RACC
1Y -2.7% vs -59.3% ยท 52W Pos 2% vs 0%
Options & Structure Winner
RACC
UNCLASSIFIED (N/A IV) vs BREAKDOWN (9th %ile IV)
RACC
US Equity
RACC
Institutional Equity
$10.02
+0.1% 1D
Market Cap
N/A
1M Return
-1.09%
1Y Return
-2.72%
Forward P/E
N/M
Unified AI Score
42.1 / 100
HOLD
Tech 39.0
Fund 38.0
Flow 50.0
Mom 38.9
MPLT
US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$5.94
-7.48% 1D
Market Cap
$356.8M
1M Return
-28.0%
1Y Return
-59.32%
Forward P/E
N/M
Unified AI Score
48.3 / 100
HOLD
Tech 33.0
Fund 64.0
Flow 67.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RACC -2.72%
MPLT -59.32%
Spread: +75.92 pp (RACC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RACC TTM Op. Margin: N/A
MPLT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RACC vs MPLT. Trailing 12-month operating profitability (RACC N/A vs MPLT 0.0%) and valuation multiples (RACC N/M vs MPLT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RACC | MPLT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $356.8M | Larger Scale | MPLT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | MPLT |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | MPLT |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | MPLT |
| Return on Equity (ROE) Capital Efficiency | N/A | -74.2% | Higher ROE | MPLT |
| 52-Week Range Position Momentum | 2% ($10โ$34) | 0% ($6โ$40) | Stronger Trend | RACC |
| Beta / 30D Volatility Risk Regime | 0.16ฮฒ ยท 6% Vol | 1.19ฮฒ ยท 79% Vol | Lower Realized Risk | RACC |
| Unified Institutional Score Composite Signal | 42.1 / 100 (HOLD) | 48.3 / 100 (HOLD) | Higher Composite | MPLT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RACC vs MPLT Buy Guide
RACC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MPLT
BREAKDOWN
148d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RACC nor MPLT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.